throbber
Eye Health A-Z
`
`Anti-VEGF Treatments
`
`Anti-VEGF Treatments
`
`What Is Avastin?
`
`What Is Lucentis?
`
`What Is Eylea?
`
`What Is Avastin?
`
`Leer en Español: ¿Qué es Avastin?
`
`By David Turbert
`Reviewed By Ninel Z Gregori MD
`Mar. 08, 2022
`Avastin is a drug used to treat wet age-related macular degeneration (AMD). It is also used to treat
`diabetic eye disease and other problems of the retina. It is injected into the eye to help slow vision
`loss from these diseases.
`
`Avastin is the brand name for the drug, which is called bevacizumab. It blocks the growth and leaking
`of fluid from abnormal blood vessels in the back of the eye. Those blood vessels can leak and affect
`vision, causing vision loss from wet AMD and diabetic eye disease.
`
`Avastin was first approved by the Food and Drug Administration (FDA) to treat different types of
`cancer. Its use to treat eye disease is considered an “off-label” use. The FDA allows “off label” drug
`use if doctors are well informed about the product and studies prove the drug is helpful. Many studies
`have shown Avastin as safe and effective for eye disease since it was first used in 2005.
`
`Lucentis® (ranibizumab) and Eylea® (aflibercept) are other drugs like Avastin. Research shows each
`of these drugs are effective in slowing vision loss.
`
`How does Avastin work?
`Abnormal blood vessels need a body chemical called VEGF to grow. Avastin blocks VEGF, slowing
`the growth of blood vessels in the eye. Drugs that block the trouble-causing VEGF are called anti-
`VEGF drugs.
`
`What conditions are treated with Avastin?
`Avastin is used to treat the following eye problems:
`
`wet age-related macular degeneration (AMD)
`swelling of the retina, called macular edema
`diabetic retinopathy
`retinal vein occlusion
`
`What happens during Avastin treatment?
`During an outpatient procedure, your ophthalmologist first numbs the eye to block pain. Then your
`doctor injects the Avastin directly into your eye.
`
`Before the procedure, your ophthalmologist will clean your eye to prevent infection and numb your
`eye with medicine. A very thin needle is passed through the white part of your eye and the drug is
`injected. Usually you do not see the needle itself. You may need to continue having these injections
`over many months.
`
`Sometimes ophthalmologists will combine Avastin treatment with other treatments for the best
`chance of saving your vision.
`
`Regeneron Exhibit 1184.001
`Regeneron v. Novartis
`IPR2021-00816
`
`

`

`What are the risks of Avastin treatment?
`Every treatment can have side effects. It is important to understand the benefits and risks of any
`treatment you might have.
`
`Common side effects include:
`
`eye redness
`feeling like something is in your eye
`dry or itchy eyes
`eye discomfort
`temporary blurry vision
`floaters
`
`Any eye injection, including Avastin, may cause these problems, which are very rare:
`
`being extra sensitive to light
`eye pain
`swelling inside the eye
`eye infection
`detached retina (where the retina lifts up from the back of the eye)
`cataracts (clouding of the eye’s normally clear lens)
`
`Call your ophthalmologist right away if you have any of these problems within a few days of Avastin
`treatment.
`
`If you have any questions about your eyes or your vision, be sure to ask. Your ophthalmologist is
`committed to protecting your sight.
`
`Previous
`Anti-VEGF Treatments
`
`Next
`What Is Lucentis?
`
`Related
`
`Macular Degeneration and Cataract Surgery: Are They
`Compatible?
`MAR 23, 2022
`
`What Is Optical Coherence Tomography?
`MAR 08, 2022
`
`What Are Drusen?
`MAR 08, 2022
`
`What Is Macular Degeneration?
`FEB 10, 2022
`
`Regeneron Exhibit 1184.002
`Regeneron v. Novartis
`IPR2021-00816
`
`

`

`The First Alternative to a Monthly Injection for Wet
`AMD
`JAN 04, 2022
`
`Search
`
`
`
`Find an Ophthalmologist
`
`Enter ZIP Code
`
`Advanced Search
`
`Ask an Ophthalmologist
`
`Search questions
`
`Browse Answers
`
`Free Newsletter
`
`Get ophthalmologist-reviewed tips and information about eye health and preserving your vision.
`
`Email Address
`Sign up
`
`Privacy Policy
`
`
`
`Contact Us
`
`Terms of Service
`
`About the Academy
`
`Help For Advertisers
`
`Jobs at the Academy
`
`For Media
`
`Financial Relationships
`with Industry
`
`Ophthalmology Job
`Center
`
`OUR SITES
`
`EyeWiki
`
`International Society of
`Refractive Surgery
`
`FOLLOW THE ACADEMY
`
`Medical Professionals
`
`
`
`
`
`
`
`Public & Patients
`
`
`
`
`
`
`
`Museum of the Eye
`
`Regeneron Exhibit 1184.003
`Regeneron v. Novartis
`IPR2021-00816
`
`

`

`Medical Disclaimer
`
`
`
`Privacy Policy
`
`
`
`
`
`
`
`
`
`
`
`© American Academy of Ophthalmology 2022
`
`ALSO OF INTEREST
`
`Lucentis
`Eye Injections
`Vegf
`
`Regeneron Exhibit 1184.004
`Regeneron v. Novartis
`IPR2021-00816
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket